Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)

About the company

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

380

$79.00M

Total Revenue

380

Employees

$632.04M

Market Capitalization

-3.12

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$68M

Operating Margin (in %)

Total operating margin

$-182M

Net Margin (in %)

Total net margin

$-200M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 11818.68 2872.00 5.94 113.31 3.63
Horizon Therapeutics Plc HZNP 11795.70 1376.00 5.03 18.60 43.06
Perrigo Co. Plc PRGO 7959.70 4837.00 1.36 54.30 3.02
Bausch Health Cos., Inc. BHC 6583.45 8597.00 9.19 -3.48 -21.96
Jazz Pharmaceuticals Plc JAZZ 6239.22 2188.00 2.16 22.80 12.81
United Therapeutics Corp. UTHR 5208.59 1443.00 1.81 10.05 36.59
MyoKardia, Inc. MYOK 4337.34 34.00 12.61 -13.99 -201.73
Axsome Therapeutics, Inc. AXSM 2873.15 None 19.50 -31.94 None
Pacira Biosciences, Inc. PCRX 2414.16 435.00 6.47 -5748.00 -0.02
SAGE Therapeutics, Inc. SAGE 2353.00 9.00 2.77 -3.63 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Prestige Consumer Healthcare, Inc. PBH 2006.85 963.00 1.69 14.15 14.77
Corcept Therapeutics, Inc. CORT 1989.82 335.00 4.57 18.75 31.64
Ironwood Pharmaceuticals, Inc. IRWD 1624.95 440.00 -23.00 19.17 19.14
Innoviva, Inc. INVA 1559.40 285.00 3.69 8.07 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1558.95 0.00 4.16 -15.26 -624.74
Revolution Medicines, Inc. RVMD 1534.59 48.00 3.98 -21.68 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1431.04 272.00 -42.59 -4.17 -127.53
Supernus Pharmaceuticals, Inc. SUPN 1346.76 402.00 2.14 11.55 28.90
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1321.20 5.00 3.61 -3.11 -241.62
Theravance Biopharma, Inc. TBPH 1255.14 88.00 -8.81 -5.09 -280.80
Revance Therapeutics, Inc. RVNC 1153.38 0.00 4.55 -6.18 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.17 327.00 2.49 19.55 15.90
BellRing Brands, Inc. BRBR 805.74 954.00 -0.44 6.11 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Eagle Pharmaceuticals, Inc. EGRX 711.20 192.00 3.82 282.22 1.29
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Aerie Pharmaceuticals, Inc. AERI 632.04 79.00 5.01 -3.12 -252.92
Collegium Pharmaceutical, Inc. COLL 590.24 299.00 4.22 -45.68 -4.21
Intersect ENT, Inc. XENT 576.80 102.00 5.45 -11.55 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 529.20 125.00 1.83 19.09 22.73
BioDelivery Sciences International, Inc. BDSI 414.92 130.00 5.93 -56.38 -5.01
ANI Pharmaceuticals, Inc. ANIP 354.72 203.00 1.81 -227.38 -0.67
Albireo Pharma, Inc. ALBO 309.92 11.00 3.15 -4.05 -730.55
MEI Pharma, Inc. MEIP 290.50 5.00 5.00 -7.45 -539.48
Mallinckrodt Plc MNK 260.40 3037.00 0.14 -0.22 -39.56
Agile Therapeutics, Inc. AGRX 149.86 None 2.44 -7.26 None
Cerecor, Inc. CERC 118.68 7.00 7.59 -5.27 -429.22
Marinus Pharmaceuticals, Inc. MRNS 115.92 0.00 5.26 -1.72 None
Ampio Pharmaceuticals, Inc. AMPE 92.95 1.00 65.00 -5.00 None
AcelRx Pharmaceuticals, Inc. ACRX 86.40 2.00 -1.59 -1.54 -644.25
Evoke Pharma, Inc. EVOK 85.44 397.00 29.67 -12.71 -0.76
Aclaris Therapeutics, Inc. ACRS 83.23 4.00 1.46 -0.60 None
Zynerba Pharmaceuticals, Inc. ZYNE 81.88 0.00 1.34 -2.28 -699.94
CTI BioPharma Corp. CTIC 81.42 3.00 3.63 -1.97 -111.83
Oramed Pharmaceuticals, Inc. ORMP 77.14 3.00 2.80 -7.12 -398.34
Adamas Pharmaceuticals, Inc. ADMS 75.04 57.00 -4.79 -0.81 -160.44
Cassava Sciences, Inc. SAVA 64.41 41.00 3.39 -14.13 76.71
Acasti Pharma, Inc. ACST 58.65 0.00 4.93 -2.30 -611.47
Natural Alternatives International, Inc. NAII 50.26 114.00 0.69 -13.30 -3.19
Cumberland Pharmaceuticals, Inc. CPIX 49.35 47.00 1.00 -10.97 -9.59
SCYNEXIS, Inc. SCYX 46.92 0.00 9.86 -1.21 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Lipocine, Inc. LPCN 38.70 0.00 9.21 -2.58 None
Neos Therapeutics, Inc. NEOS 31.75 65.00 -2.44 -1.81 -26.74
PLx Pharma, Inc. PLXP 25.74 0.00 -2.47 -2.72 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.64 3.00 2.57 -1.74 -264.21
Regulus Therapeutics, Inc. RGLS 16.38 0.00 1.44 -0.76 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 11.47 None 1.48 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.02 None 1.77 3.01 None
Sonoma Pharmaceuticals, Inc. SNOA 6.61 19.00 1.50 -3.32 -15.56
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.72 73.00 -0.13 -0.19 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 3.99 None 1.00 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Aerie Pharmaceuticals Inc.

5d ago, source: MarketWatch

02/24/2016 10,000 Award at $0 per share. 0 ...

Aerie Pharmaceuticals Inc (NASDAQ:AERI) Shares Sold by Morgan Stanley

8d ago, source: theenterpriseleader.com

Morgan Stanley decreased its holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 12.8% during the 1st quarter, according ...

Aerie Pharmaceuticals Inc (NASDAQ:AERI) Shares Purchased by Deutsche Bank AG

10d ago, source: theenterpriseleader.com

Deutsche Bank AG boosted its stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 20.7% during the 1st quarter, according to ...

Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex

7d ago, source: YAHOO!

Aerie Pharmaceuticals, Inc. AERI signed an agreement to acquire privately-held Spanish ophthalmic pharmaceutical company, Avizorex Pharma, to boost its dry eye disease pipeline. Aerie will pay $10 ...

Aerie Pharmaceuticals Inc (AERI): Hedge Funds Are Nibbling

1mon ago, source: Yahoo! News

However, in this article we will take a look at their collective moves over the last 4.5 years and analyze what the smart money thinks of Aerie Pharmaceuticals Inc (NASDAQ:AERI) based on that data. In ...

Aerie Completes Enrollment Under Rhopressa Study in Japan

8d ago, source: YAHOO!

Aerie Pharmaceuticals, Inc. AERI announced that it has completed enrollment in its double-masked, multi-center, placebo-controlled, parallel group phase II study on Rhopressa (netarsudil ...

Financials Aerie Pharmaceuticals

16d ago, source: Business Insider

Share Earnings Data (in USD) Aerie Pharmaceuticals Inc: Key Data (in USD) ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.